Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 106 · FY2023 274 · FY2024 857 — 3-yr total 1,237
Operates in Pharma. Per the activity note to the FY2024 annual report, the company wholesales and manufactures food additives and dyes.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 490 | 677 | 1,319 | 1,922 | 2,281 | 2,015 | 2,828 | +33.9% | |
| 872 | 875 | 840 | 797 | 783 | 957 | 933 | +1.1% | |
| TOTAL ASSETS | 1,363 | 1,552 | 2,159 | 2,718 | 3,064 | 2,971 | 3,761 | +18.4% |
| 268 | 237 | 394 | 384 | 737 | 470 | 298 | +1.8% | |
| Total Non-Current Liabilities | 0 | 0 | 0 | 152 | 90 | 179 | 1,041 | nmf |
| TOTAL LIABILITIES | 268 | 237 | 394 | 537 | 828 | 649 | 1,339 | +30.8% |
| 1,095 | 1,315 | 1,764 | 2,181 | 2,236 | 2,322 | 2,421 | +14.1% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 104 | 0 | 0 | 268 | 208 | 199 | 1,064 | +47.3% |
| Cash & Equivalents | 62 | 150 | 209 | 680 | 370 | 443 | 661 | +48.4% |
| Net Debt | 42 | 150 | 209 | 412 | 162 | 243 | 403 | +45.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →